New York, New York (PRWEB) June 13, 2014
As Mirena IUD lawsuits (http://www.themirenalawsuitcenter.com/)
continue to mount in courts around the U.S., Bernstein Liebhard LLP notes that Bayer Healthcare Pharmaceuticals has filed a motion seeking to have a Mirena lawsuit originally filed in North Carolina’s Cleveland County Court moved to the federal court system. The complaint, which alleges the Plaintiff was forced to undergo Mirena removal surgery after the IUD spontaneously migrated and became embedded in her uterus, was filed in the state court on April 29, 2014.. (Case No. 7:14-cv-03472-CS)
“We are representing numerous women who have allegedly suffered similar Mirena complications associated with spontaneous IUD migration, and continue to receive Mirena lawsuit inquiries from others. It is not surprising that these cases continue to mount in courts around the country,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free case evaluations to women who allegedly suffered serious Mirena complications including spontaneous migration of their IUD.
According to court documents, more than 1,250 Mirena IUD lawsuits are currently pending in U.S. courts. These include at least 528 which have been filed in a federal multidistrict litigation now underway in U.S. District Court, Southern District of New York. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434) More than 720 cases are also pending in a multicounty litigation underway in New Jersey’s Bergen County Superior Court, where Bernstein Liebhard LLP is actively filing claims. (In Re: Mirena Litigation; Case No. 297)
Court records indicate that all of these Mirena lawsuits similarly allege that users of the IUD experienced spontaneous migration of the device, leading to uterine perforations, ectopic pregnancy, scarring, infertility and other related Mirena complications. Among other things, plaintiffs claim that the labeling for the IUD only notes that the device may migrate if the uterus is perforated upon insertion. It does not mention that Mirena may migrate long after it was correctly inserted by a doctor.
According to a report that was aired on 7 Action News in August 2013, the U.S. Food & Drug Administration (FDA) has logged more than 70,000 complaints involving device dislocation, uterine perforation and other Mirena side effects since the IUD was launched on the U.S. market in 2000.* In 2009, Bayer Healthcare Pharmaceuticals was cited by the FDA for a marketing campaign that the agency said exaggerated the IUD's benefits and downplayed the risk of serious Mirena complications.
Women who suffered uterine perforations, infertility, and other Mirena complications allegedly associated with spontaneous device migration may be eligible to file their own Mirena IUD lawsuit. To learn more about the risks allegedly linked to spontaneous Mirena migration, please visit Bernstein Liebhard LLP's website, or the Firm's Facebook page: https://www.facebook.com/mirenalawsuithelp. For a free and confidential evaluation of a potential Mirena lawsuit, please call 800-511-5092.
*wxyz.com/dpp/news/local_news/investigations/thousands-of-women-complain-about-dangerous-complications-from-mirena-iud-birth-control, 7 Action News, August 27, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State's contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm's fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff's recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com